How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries?
Descripción del Articulo
Advances in molecular diagnostics have led to improved stratification and targeted interventions in the treatment of children with brain tumors. This has necessitated complex infrastructure to deliver all the required testing in a clinically useful time period. However, in less-resourced countries,...
| Autores: | , , , , , , , , , , , , |
|---|---|
| Formato: | revisión |
| Fecha de Publicación: | 2022 |
| Institución: | Instituto Nacional de Enfermedades Neoplásicas |
| Repositorio: | INEN-Institucional |
| Lenguaje: | inglés |
| OAI Identifier: | oai:repositorio.inen.sld.pe:20.500.14703/324 |
| Enlace del recurso: | https: //doi.org/10.1200/GO.22.00156 https://hdl.handle.net/20.500.14703/324 |
| Nivel de acceso: | acceso abierto |
| Materia: | Brain Neoplasms Child Developing Countries Genomics Humans Income https://purl.org/pe-repo/ocde/ford#3.02.21 |
| id |
INEN_ac26cd1bea3b4789de6348c6feef951d |
|---|---|
| oai_identifier_str |
oai:repositorio.inen.sld.pe:20.500.14703/324 |
| network_acronym_str |
INEN |
| network_name_str |
INEN-Institucional |
| repository_id_str |
. |
| spelling |
PublicationBailey, SDavidson, AAParkes, JTabori, UFigaji, AEpari, SChinnaswamy, GDias-Coronado, RCasavilca-Zambrano, SAmayiri, NVassal, GBouffet, EClifford, SC2025-01-02T14:42:38Z2025-01-02T14:42:38Z2022https: //doi.org/10.1200/GO.22.00156https://hdl.handle.net/20.500.14703/324JCO global oncologyAdvances in molecular diagnostics have led to improved stratification and targeted interventions in the treatment of children with brain tumors. This has necessitated complex infrastructure to deliver all the required testing in a clinically useful time period. However, in less-resourced countries, this testing is not routinely available and an ever-widening gap in the ability to deliver more tailored therapies including targeted agents is increasingly evident. This article reviews the recent advances and suggests practical ways of ensuring that genomic advances are applied according to available resources.application/pdfengLippincott Williams and WilkinsUSinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/4.0/Brain NeoplasmsChildDeveloping CountriesGenomicsHumansIncomehttps://purl.org/pe-repo/ocde/ford#3.02.21How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries?info:eu-repo/semantics/reviewinfo:eu-repo/semantics/publishedVersionreponame:INEN-Institucionalinstname:Instituto Nacional de Enfermedades Neoplásicasinstacron:INENORIGINALgo-8-e2200156.pdfapplication/pdf300788https://repositorio.inen.sld.pe/backend/api/core/bitstreams/4b1b51d5-01ed-445f-8422-285763033867/downloada1e93ed55c0b8858b93686aae0c3c11aMD51trueAnonymousREADTEXTgo-8-e2200156.pdf.txtWritten by FormatFilter org.dspace.app.mediafilter.TikaTextExtractionFilter on 2025-08-22T08:05:26Z (GMT).Extracted texttext/plain65047https://repositorio.inen.sld.pe/backend/api/core/bitstreams/b7a4b4a0-1f47-4cdb-9ea4-4a34fa809dc3/download35161e79253a1e4a967e9cbbb2e6bf1eMD52falseAnonymousREADTHUMBNAILgo-8-e2200156.pdf.jpgWritten by FormatFilter org.dspace.app.mediafilter.PDFBoxThumbnail on 2025-08-22T08:05:26Z (GMT).Generated Thumbnailimage/jpeg49150https://repositorio.inen.sld.pe/backend/api/core/bitstreams/58b1f441-bba3-4bdc-a2ec-1dd7b1a320a4/downloade2aaefc1dff931ad4608a7e671cfb921MD53falseAnonymousREAD20.500.14703/324oai:repositorio.inen.sld.pe:20.500.14703/3242026-02-15T18:16:30.271Zhttps://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessopen.accesshttps://repositorio.inen.sld.peRepositorio del Instituto Nacional de Enfermedades Neoplásicasrepositorio@inen.sld.pe |
| dc.title.none.fl_str_mv |
How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries? |
| title |
How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries? |
| spellingShingle |
How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries? Bailey, S Brain Neoplasms Child Developing Countries Genomics Humans Income https://purl.org/pe-repo/ocde/ford#3.02.21 |
| title_short |
How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries? |
| title_full |
How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries? |
| title_fullStr |
How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries? |
| title_full_unstemmed |
How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries? |
| title_sort |
How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries? |
| author |
Bailey, S |
| author_facet |
Bailey, S Davidson, AA Parkes, J Tabori, U Figaji, A Epari, S Chinnaswamy, G Dias-Coronado, R Casavilca-Zambrano, S Amayiri, N Vassal, G Bouffet, E Clifford, SC |
| author_role |
author |
| author2 |
Davidson, AA Parkes, J Tabori, U Figaji, A Epari, S Chinnaswamy, G Dias-Coronado, R Casavilca-Zambrano, S Amayiri, N Vassal, G Bouffet, E Clifford, SC |
| author2_role |
author author author author author author author author author author author author |
| dc.contributor.author.fl_str_mv |
Bailey, S Davidson, AA Parkes, J Tabori, U Figaji, A Epari, S Chinnaswamy, G Dias-Coronado, R Casavilca-Zambrano, S Amayiri, N Vassal, G Bouffet, E Clifford, SC |
| dc.subject.none.fl_str_mv |
Brain Neoplasms Child Developing Countries Genomics Humans Income |
| topic |
Brain Neoplasms Child Developing Countries Genomics Humans Income https://purl.org/pe-repo/ocde/ford#3.02.21 |
| dc.subject.ocde.none.fl_str_mv |
https://purl.org/pe-repo/ocde/ford#3.02.21 |
| description |
Advances in molecular diagnostics have led to improved stratification and targeted interventions in the treatment of children with brain tumors. This has necessitated complex infrastructure to deliver all the required testing in a clinically useful time period. However, in less-resourced countries, this testing is not routinely available and an ever-widening gap in the ability to deliver more tailored therapies including targeted agents is increasingly evident. This article reviews the recent advances and suggests practical ways of ensuring that genomic advances are applied according to available resources. |
| publishDate |
2022 |
| dc.date.accessioned.none.fl_str_mv |
2025-01-02T14:42:38Z |
| dc.date.available.none.fl_str_mv |
2025-01-02T14:42:38Z |
| dc.date.issued.fl_str_mv |
2022 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/review |
| dc.type.version.none.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| format |
review |
| status_str |
publishedVersion |
| dc.identifier.doi.none.fl_str_mv |
https: //doi.org/10.1200/GO.22.00156 |
| dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/20.500.14703/324 |
| dc.identifier.journal.none.fl_str_mv |
JCO global oncology |
| url |
https: //doi.org/10.1200/GO.22.00156 https://hdl.handle.net/20.500.14703/324 |
| identifier_str_mv |
JCO global oncology |
| dc.language.iso.none.fl_str_mv |
eng |
| language |
eng |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| dc.rights.uri.none.fl_str_mv |
https://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0/ |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Lippincott Williams and Wilkins |
| dc.publisher.country.none.fl_str_mv |
US |
| publisher.none.fl_str_mv |
Lippincott Williams and Wilkins |
| dc.source.none.fl_str_mv |
reponame:INEN-Institucional instname:Instituto Nacional de Enfermedades Neoplásicas instacron:INEN |
| instname_str |
Instituto Nacional de Enfermedades Neoplásicas |
| instacron_str |
INEN |
| institution |
INEN |
| reponame_str |
INEN-Institucional |
| collection |
INEN-Institucional |
| bitstream.url.fl_str_mv |
https://repositorio.inen.sld.pe/backend/api/core/bitstreams/4b1b51d5-01ed-445f-8422-285763033867/download https://repositorio.inen.sld.pe/backend/api/core/bitstreams/b7a4b4a0-1f47-4cdb-9ea4-4a34fa809dc3/download https://repositorio.inen.sld.pe/backend/api/core/bitstreams/58b1f441-bba3-4bdc-a2ec-1dd7b1a320a4/download |
| bitstream.checksum.fl_str_mv |
a1e93ed55c0b8858b93686aae0c3c11a 35161e79253a1e4a967e9cbbb2e6bf1e e2aaefc1dff931ad4608a7e671cfb921 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio del Instituto Nacional de Enfermedades Neoplásicas |
| repository.mail.fl_str_mv |
repositorio@inen.sld.pe |
| _version_ |
1868438561993261056 |
| score |
12.824051 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).